Trevena Analyst Ratings
Buy Rating Affirmed on Trevena as Focus Shifts to Promising Drug Candidate TRV045
Buy Rating Affirmed for Trevena Amid Strategic Focus on Promising TRV045 Development
Trevena Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Trevena (TRVN), MoonLake Immunotherapeutics (MLTX) and Senseonics Holdings (SENS)
Analysts Offer Insights on Healthcare Companies: Trevena (TRVN) and Immunic (IMUX)
Analysts' Top Healthcare Picks: Ambrx Biopharma (AMAM), Trevena (TRVN)
JMP Securities Remains a Buy on Trevena (TRVN)
JMP Securities Remains a Buy on Trevena (TRVN)
Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and Trevena (TRVN)
JMP Securities Reiterates Market Outperform on Trevena, Maintains $2 Price Target
JMP Securities Sticks to Their Buy Rating for Trevena (TRVN)
JMP Securities Keeps Their Buy Rating on Trevena (TRVN)
JMP Securities Reiterates Market Outperform on Trevena, Maintains $2 Price Target
Analysts' Opinions Are Mixed on These Healthcare Stocks: Trevena (TRVN), Akebia Therapeutics (AKBA) and Fennec Pharmaceuticals (FENC)
HC Wainwright & Co. Reiterates Buy on Trevena, Lowers Price Target to $9
JMP Securities Sticks to Its Buy Rating for Trevena (TRVN)
JMP Securities Keeps Their Buy Rating on Trevena (TRVN)
Analysts Offer Insights on Healthcare Companies: Trevena (TRVN) and Nkarta (NKTX)
Analysts Are Bullish on Top Healthcare Stocks: Trevena (TRVN), Zealand Pharma (ZEAL)
No Data